These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3104161)

  • 1. Immune status in thalassemia major.
    Neri A; Callea V; D'Ascola DG; Martino B
    Haematologica; 1986; 71(6):511-6. PubMed ID: 3104161
    [No Abstract]   [Full Text] [Related]  

  • 2. Transfusion-related immunologic abnormalities in beta-thalassemia major.
    Grady RW; Akbar AN; de Sousa M; Giardina PJ; Hilgartner MW
    Birth Defects Orig Artic Ser; 1987; 23(5A):587-93. PubMed ID: 3689945
    [No Abstract]   [Full Text] [Related]  

  • 3. Immune profile alterations in thalassaemic patients.
    Quintiliani L; Mastromonaco A; Giuliani E; Buzzonetti A; Sisti P; Guglielmetti M; Iudicone P; Greca E; Damiano AM; Ciancamerla AM
    Boll Ist Sieroter Milan; 1983; 62(6):524-30. PubMed ID: 6677264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic status of Hb E-thalassemia patients.
    Swarup-Mitra S
    Birth Defects Orig Artic Ser; 1987; 23(5A):571-9. PubMed ID: 3689944
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunologic studies in thalassemia major].
    Sen L; Goicoa MA; Nualart PJ; Ballart IJ; Palacios F; Diez RA; Estévez ME
    Medicina (B Aires); 1989; 49(2):131-4. PubMed ID: 2640481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of blood transfusion on the immune response of children with thalassaemia.
    Kanakoudi-Tsakalidis F; Spyroglou K; Tzafi R; Cassimos C
    Acta Haematol; 1977; 57(2):65-73. PubMed ID: 402767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron-related disturbances of cell-mediated immunity in multitransfused children with thalassemia major.
    Pardalos G; Kanakoudi-Tsakalidis F; Malaka-Zafiriu M; Tsantali H; Athanasiou-Metaxa M; Kallinikos G; Papaevangelou G
    Clin Exp Immunol; 1987 Apr; 68(1):138-45. PubMed ID: 3498564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impairment of natural killer (NK) function in carriers and patients with thalassemia major.
    Goicoa MA; Estevez ME; Ballart IJ; Diez RA; Peñalver JA; de Miani SA; Sen L
    Nouv Rev Fr Hematol (1978); 1986; 28(2):75-9. PubMed ID: 3737398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in immunologic indices in dilated cardiomyopathy].
    Amosova EN; Taradiĭ NN; Sidorova LL; Romashko VV
    Vrach Delo; 1988 Sep; (9):41-4. PubMed ID: 3212993
    [No Abstract]   [Full Text] [Related]  

  • 10. Human growth hormone iso-antibodies in the plasma of multiply transfused children with thalassemia.
    Genazzani AR; Vierucci A
    Folia Endocrinol; 1972 Oct; 25(5):401-10. PubMed ID: 4679242
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of the potentially immunodeficient patient.
    Fleisher TA
    Adv Intern Med; 1996; 41():1-30. PubMed ID: 8903585
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibody to hepatitis-C virus in multitransfused thalassaemics--Indian experience.
    Bhattacharya DK
    J Assoc Physicians India; 1994 Feb; 42(2):174. PubMed ID: 7532165
    [No Abstract]   [Full Text] [Related]  

  • 13. The genetic relationships of Australia antigen.
    London WT
    Vox Sang; 1973; 24():Suppl:1-7. PubMed ID: 4124190
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunologic reactivity in thalassemia.
    Boonpucknavig S; Chiewsilp P; Isarangkura P; O'Charoen R; Akkawat R
    Birth Defects Orig Artic Ser; 1987; 23(5A):565-9. PubMed ID: 3500746
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunoregulatory functions of gamma delta T cells.
    Born W; Cady C; Jones-Carson J; Mukasa A; Lahn M; O'Brien R
    Adv Immunol; 1999; 71():77-144. PubMed ID: 9917911
    [No Abstract]   [Full Text] [Related]  

  • 16. Leukocyte antibodies in thalassemic patients.
    Sujirachato K; Chiewsilp P; Isarangkura P
    Birth Defects Orig Artic Ser; 1988; 23(5B):283-5. PubMed ID: 3390553
    [No Abstract]   [Full Text] [Related]  

  • 17. Lymphocyte subsets and specific T-cell immune response in thalassemia.
    Pattanapanyasat K; Thepthai C; Lamchiagdhase P; Lerdwana S; Tachavanich K; Thanomsuk P; Wanachiwanawin W; Fucharoen S; Darden JM
    Cytometry; 2000 Feb; 42(1):11-7. PubMed ID: 10679738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [On the presence and significance of anti-I and anti-H antibodies in polytransfused patients with Cooley's disease].
    Menini C; Georgacopulo P
    Minerva Chir; 1969 May; 24(9):511-7. PubMed ID: 5305938
    [No Abstract]   [Full Text] [Related]  

  • 19. HTLV-III neutralizing antibody development in transfusion-dependent seropositive patients with beta-thalassemia.
    Robert-Guroff M; Giardina PJ; Robey WG; Jennings AM; Naugle CJ; Akbar AN; Grady RW; Hilgartner MW
    J Immunol; 1987 Jun; 138(11):3731-6. PubMed ID: 3495568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Modern therapeutic possibilities in Cooley's disease].
    Carcassi U
    Atti Accad Fisiocrit Siena Med Fis; 1966; 15(2):1105-31. PubMed ID: 6001538
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.